BIOGEN INC. Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31)
BIOGEN INC. (BIIB) reported Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) of $189.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease · last filed 2012-05-01
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $189.00K, a 1618.18% increase year-over-year.
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-03-31 was $11.00K.
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2010-12-31 was -$1.84M.
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2010-09-30 was $200.00K.
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$9.28M.
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2010 was -$1.94M, a 487.62% decline from fiscal 2009.
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2009 was $501.00K.
- BIOGEN INC. other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2008 was -$43.00K.
| Period end | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $189.00K 10-Q · filed 2012-05-01 | |||
| 2011-12-31 | -$9.28M 10-K · filed 2012-02-03 | |||
| 2011-03-31 | $11.00K 10-Q · filed 2012-05-01 | -$1.83M derived: sum of 2 quarters · filed 2012-05-01 | -$1.63M derived: sum of 3 quarters · filed 2012-05-01 | -$1.83M derived: sum of 4 quarters · filed 2012-05-01 |
| 2010-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | -$1.64M derived: sum of 2 quarters · filed 2012-02-03 | -$1.84M derived: sum of 3 quarters · filed 2012-02-03 | -$1.94M 10-K · filed 2012-02-03 |
| 2010-09-30 | $200.00K 10-Q · filed 2011-10-28 | $0.00 derived: sum of 2 quarters · filed 2011-10-28 | -$100.00K 10-Q · filed 2011-10-28 | |
| 2010-06-30 | -$200.00K 10-Q · filed 2011-07-26 | -$300.00K 10-Q · filed 2011-07-26 | ||
| 2010-03-31 | -$100.00K 10-Q · filed 2011-04-21 | |||
| 2009-12-31 | $501.00K 10-K · filed 2012-02-03 | |||
| 2008-12-31 | -$43.00K 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |